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Abstract 
Photodynamic therapy (PDT) is a well-established treatment of cancer in which cell toxic reactive 
oxygen species, including singlet oxygen (1O2), are produced by a photosensitiser drug following 
irradiation of a specific wavelength. Visible light is commonly used as the excitation source in PDT, 
although these wavelengths do have limited tissue penetration. In this research, upconverting 
nanoparticles (UCNPs) functionalised with the photosensitiser Rose Bengal (RB) have been designed 
and synthesised for PDT of breast cancer cells. The use of UCNPs shifts the required excitation 
wavelength for the production of 1O2 to near infrared light (NIR) thus allowing deeper tissue 
penetration. The system was designed to maximise the production of 1O2 via efficient Förster 
resonance energy transfer (FRET) from the UCNPs to the photosensitiser. Highly luminescent 
NaYF4:Yb,Er,Gd@NaYF4 core-shell UCNPs were synthesised that exhibited two main anti-Stokes 
emission bands at 541 and 652 nm following 980 nm irradiation. RB was chosen as the photosensitiser 
since its absorption band overlaps with the green emission of the UCNPs. To achieve efficient energy 
transfer from the nanoparticles to the photosensitiser, the functionalised UCNPs included a short L-
lysine linker to attach the RB to the nanocore yielding RB-lysine functionalised UCNPs. The efficient 
FRET from the UCNPs to the RB was confirmed by luminescence lifetime measurements. The light 
emitted by the UCNPs at 541 nm, following excitation at 980 nm, generates the 1O2 via the RB. Multi-
photon and confocal laser scanning microscopies confirmed the internalisation of the RB-lysine-UCNPs 
by SK-BR-3 breast cancer cells. Cell viability studies revealed that the RB-lysine-UCNPs induced low 
dark toxicity in cells prior to PDT treatment. Importantly, following irradiation at 980 nm, high levels 
of cell death were observed in cells loaded with the RB-lysine-UCNPs. Cell death following PDT 
treatment was also confirmed using propidium iodide and confocal microscopy. The high drug loading 
capacity (160 RB/nanoparticle) of the UCNPs, the efficient FRET from the UCNPs to the 
photosensitiser, the high level of accumulation inside the cells and their PDT cell kill suggest that the 
RB-lysine-UCNPs are promising for NIR PDT and hence suitable for the treatment of deep-lying cancer 
tumours. 
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Introduction 
Photodynamic therapy (PDT) is a treatment for cancer that involves the production of reactive oxygen 
species which leads to cell death. Reactive oxygen species, including singlet oxygen (1O2), are 
generated by the activation of a photosensitiser drug with light, typically of visible wavelengths.1 
Particularly effective photosensitisers are hydrophobic in nature, since they can be efficiently 
internalised by the cells through interaction with the lipid layers of the cell membrane.2, 3 However, 
such hydrophobicity restricts the delivery and transportation of the photosensitisers through the 
body.2, 4 Another issue with photosensitisers that are activated with visible light is the difficulty to treat 
deep-lying tumours.5 Therefore, improvements for the extended use of PDT in the clinical 
environment include the development of photosensitiser delivery systems that can provide aqueous 
solubility, as well as the use of excitation wavelengths in the near-infrared (NIR) region that can 
increase tissue penetration. 
Upconverting nanoparticles (UCNPs) have attracted considerable interest as delivery vehicles for 
photodynamic therapy.5 UCNPs convert NIR light to ultraviolet (UV) and visible light, which can then 
be used for the excitation of photosensitisers placed near the surface of the UCNPs.5 The use of NIR 
light has several advantages over UV and visible light, including deeper penetration into biological 
tissue, reduced photodamage upon long-term irradiation, increased photostability and low 
autofluorescence.5-8 UCNPs are commonly prepared with lanthanide ions, which are embedded in a 
crystalline host lattice.9 Such a host lattice is physically and chemically stable and requires low phonon 
energies,10 so that non-radiative loss can be minimised while the upconverted emission is maximised.7, 
9, 11 The lanthanide dopants typically consist of ytterbium (Yb3+) ions as sensitiser ions, which can 
absorb the NIR light and transfer two or more photons to the so-called emitting ions (e.g. erbium 
(Er3+), holmium (Ho3+) and thulium (Tm3+) ions), yielding anti-Stokes emissions.7, 9, 11 
Thermolysis, Ostwald ripening and a hydrothermal strategy are the three main synthetic methods for 
UCNPs.6 Depending on the performed synthesis, several surface modifications are necessary either to 
enhance the colloidal stability of the nanoparticles or to provide functional groups on the surface of 
the particles for coupling with other ligands such as biomolecules and/or photosensitisers.6, 12, 13 The 
most important consideration when using UCNPs for PDT is the overlap between the luminescence 
emission of the UCNPs and the absorption of the photosensitiser, enabling an activation of the 
photosensitiser by the NIR light.5 Therefore, the surface modification and functionalisation of the 
UCNPs with the photosensitiser is critical to achieve efficient photodynamic therapy.14 Several surface 
modifications and functionalisation methods have been explored. The first reports of UCNPs for PDT 
involved the coating of the UCNPs with an amorphous silica layer, to which the photosensitiser was 
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embedded.15, 16 Despite the promising results obtained, the silica coating was found to present various 
limitations, including the low loading of the photosensitiser due to its weak interaction with the silica, 
the low stability of silica in aqueous solutions and the restricted site of action of singlet oxygen, which 
is unable to be efficiently released from the silica layer.17, 18 These limitations could be improved by 
covalent conjugation of the photosensitiser to the silica layer,17 or by the use of mesoporous silica 
(mSiO2), which further improves the aqueous solubility of the system and increases the PDT efficacy 
due to an improved release of 1O2.18, 19 The addition of an extra outer layer made of a cross-linked lipid 
to the mSiO2-UCNPs is a further advantage to avoid the leaking of the photosensitiser from the silica 
layer.20 
The use of hydrophilic and amphiphilic polymers have also been widely studied. Polyethylene glycol 
(PEG) is one such polymer that can induce water solubility and biocompatibility with good results in 
NIR-PDT, either used by itself,21 or as a copolymer.22-24 The addition of PEG has also been reported to 
increase the stability in a system where the photosensitiser was deposited as a layer around the 
UCNPs.25 An additional advantage of PEG is its use as a linker for targeting molecules, such as folic 
acid.26 Other polymers that have been used to modify the surface of UCNPs in PDT include 
polyethyleneimide,27 chitosan,28, 29 and a polymeric liposome made of three amphiphilic polymers.30 
The modification of oleate-capped UCNPs with a cyclic oligosaccharide, α-cyclodextrin, yielded water 
stable and biocompatible UCNPs useful for PDT.31 A new synthetic approach applying nucleotides to 
render water dispersible UCNPs without the need of ligand exchange surface modification has been 
reported by Zhou et al..32 
A significant problem with the current functionalisation methods is the increase in the distance 
between the emitting ions in the UCNPs and the photosensitisers, due to the inclusion of the extra 
layer of either silica or polymers between the two.33 The distance between the surface of the UCNPs 
and the photosensitiser needs to be considered as an important parameter, since the energy transfer 
efficiency is distance-dependent; it decreases proportionally to the sixth power of the distance 
between the donor and the acceptor species.33, 34 As a result, the efficiency of 1O2 production and thus 
photodynamic therapy is reduced. 
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Here, we report the synthesis of a novel nanoplatform that includes small and bright UCNPs modified 
with a short biocompatible linker molecule, L-lysine, to which the photosensitiser Rose Bengal (RB) 
was covalently attached (Fig. 1). The nanoparticles exhibit structural advantages including: 1) high 
drug loading on the surface of the nanoparticles; 2) short distance between the nanoparticle and the 
photosensitiser; and 3) colloidal stability. The Rose Bengal (RB)-lysine functionalised UCNPs generated 
singlet oxygen via efficient Förster resonance energy transfer (FRET) between the UCNP and the 
photosensitiser. The use of the UCNPs for photodynamic therapy of cancer was investigated in vitro 
using SK-BR-3 human breast cancer cells. The RB-lysine functionalised UCNPs were internalised by the 
SK-BR-3 cells as demonstrated using confocal laser scanning microscopy and multi-photon 
microscopy. Furthermore, cell viability and cytotoxicity studies performed before and after PDT 
treatment confirmed the high efficiency of the RB-lysine functionalised UCNPs for PDT of cancer. 
 
 
Fig. 1. Schematic representation of the Rose Bengal – lysine functionalised UCNPs used for photodynamic 
therapy of breast cancer cells. The UCNPs (green) were excited at 980 nm to produce luminescence emission at 
541 nm that excited the Rose Bengal (red molecule) to produce singlet oxygen (1O2), toxic for the cancer cells. 
 
 
Experimental Section 
Materials 
All of the reagents used were of analytical grade, purchased from Sigma-Aldrich, unless otherwise 
stated, and used as received. Sodium dihydrogen orthophosphate dihydrate (NaH2PO4·2H2O), sodium 
chloride (NaCl), phosphate buffered saline (PBS) tablets, foetal bovine serum, 75 cm2 Nunc Easy tissue 
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culture flasks with porous caps, Nunc multidishes, Nunc Nunclon™ Δ Surface 96-well white-bottom 
microplates and 18 mm diameter glass coverslips were purchased from Thermo Fisher Scientific, UK. 
Trypsin 0.25% (1x) with ethylenediaminetetraacetic acid (EDTA) and McCOY’s 5A phenol red free 
medium containing L-glutamine were purchased from Invitrogen, UK. CellTiter-Blue® cell viability 
assay was purchased from Promega, UK. Millex GP syringe driven filter units (0.22 µm) were purchased 
from Millipore Corporation, USA. Sodium hydrogen carbonate (NaHCO3) was purchased from BDH 
Laboratory Supplies Poole, UK. 1-Octadecene (90%) and oleic acid (90%) were bought from Alfar 
Aesar. Sodium hydroxide (98-100%) and dimethyl sulfoxide (DMSO, 99.9%) were purchased from 
Merck. Cyclohexane (99.5%), dimethylformamide (DMF, 99.5%), and chloroform (99.8%) were 
obtained from Acros Organics. Yttrium chloride hexahydrate (99.99%), ytterbium chloride 
hexahydrate (99.99%) and gadolinium chloride hexahydrate (99.99%) were bought from Treibacher 
Industrie AG. L-lysine (98.5-101.5%) was purchased from SERVA. SK-BR-3 human breast 
adenocarcinoma cells were purchased from LGC Standards. The SK-BR-3 cell line was kindly provided 
by Prof Dylan R. Edwards (Norwich Medical School, University of East Anglia, UK). 
 
Instrumental 
The size of the nanoparticles was investigated with dynamic light scattering (DLS) and transmission 
electron microscopy (TEM). DLS-measurements were performed on a Zetasizer Nano ZS (Malvern) in 
semi-micro disposable poly(methyl methacrylate) (PMMA) cuvettes. For particles dispersed in DMF 
and DMSO, precision cells made of quartz glass Suprasil from Hellma were used. A 120 kV Philips CM12 
microscope (MicroCal) was used to generate TEM images, which were analysed with ImageJ/Origin 8. 
Lifetime measurements were performed with a 980 nm (cw, 200 mW) laser module and an optical 
chopper (MC2000 with a two-slot chopper blade MC1F2) from Thorlabs. The signal was amplified by 
a photomultiplier tube and analysed by a digital storage oscilloscope (DSO 8204) from Voltcraft. 
Optical bandpass filters (FF01-535/150-25 and FF01-665/150-25) from Semrock were used to measure 
luminescence decay times for the green (541 nm) and the red emission (656 nm). Fourier transform 
infrared spectroscopy (FTIR) measurements were performed on a Carry 630 FTIR spectrometer 
(Agilent Technologies). The luminescence spectra were recorded on a luminescence Aminco Bowman 
Series 2 spectrometer (Thermo Electron Corporation) coupled with a cw laser (980 nm, 200 mW). 
Inductively coupled plasma optical emission spectrometric (ICP-OES) measurements were performed 
using an ICP-OES from Spectro. 
Multi-photon microscopy was achieved using a TriM Scope II multi-photon microscope (LaVision 
BioTec, Bielefeld, Germany). The images were acquired with a 63x/1.4 NA PlanApochromat objective 
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lens (Carl Zeiss Ltd., Cambridge, UK) and processed using ImspectorPro and ImageJ/Fiji software. Laser 
scanning confocal microscopy images of SK-BR-3 cells were obtained using a Carl Zeiss LSM 510 META 
microscope. The images were acquired with a plan-apochromat 63x/1.4 Oil DIC objective and 
processed using the Zeiss LSM Image Browser software. To perform the cell viability assays, the 
samples were excited at 561 nm and the fluorescence emission was measured at 594 nm using a 
CLARIOstar® (BMG Labtech) microplate reader. 
 
Methods 
Synthesis, functionalisation and characterisation of UCNPs 
Synthesis of oleate-capped UCNPs 
The synthesis of β-NaYF4:Yb,Er,Gd core, α-NaYF4 shell precursor and NaYF4:Yb,Er,Gd@NaYF4 core-shell 
(oleate-capped) upconverting nanoparticles has been previously reported35 and is described in the 
supplementary information. 
Synthesis of BF4- capped NaYF4:Yb,Er,Gd@NaYF4 core-shell nanoparticles 
For the preparation of BF4- capped core-shell nanoparticles, a ligand exchange method was used. Equal 
volumes of cyclohexane, containing the oleate capped upconverting nanoparticles and DMF were 
stirred at 30 °C. Nitrosyltetrafluoroborate (NOBF4) was added directly into the stirring solution (1 mg 
NOBF4 for 1 mg nanoparticles). After 15 min of stirring at 30 °C, the upper phase (cyclohexane) was 
removed and the DMF phase was washed with an excess of chloroform (20 mL). After being 
centrifuged (1,000 xg, 5 min), the jelly-like precipitate was dispersed in 2-3 mL DMF and washed with 
chloroform (20 mL). Finally, the BF4- capped nanoparticles were dispersed in 2-3 mL of DMF and the 
aggregates were separated by centrifugation (1,000 xg, 3 min). 
Synthesis of L-lysine functionalised NaYF4:Yb,Er,Gd@NaYF4 core-shell nanoparticles 
6 mg L-lysine was dissolved in 2 mL doubly distilled water and was heated to 30 °C. 20 mg of BF4- 
capped core-shell nanoparticles was added to the solution and the dispersion was stirred for 15 min. 
The particles were centrifuged twice (21,000 xg, 30 min) and redispersed in 2 mL of doubly distilled 
water under sonication. 
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Synthesis of Rose Bengal (RB)-lysine functionalised NaYF4:Yb,Er,Gd@NaYF4 core-shell nanoparticles 
8 mg Rose Bengal (RB, 8 µmol) was activated with 10 mg of N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (EDC, 50 µmol) and 10 mg of N-hydroxysuccinimide ester (NHS ester 
(87 µmol) in 2 mL of 2-(N-morpholino)ethanesulfonic acid (MES, pH 5.5, 50 mM) buffer for 2 h at room 
temperature. 20 mg of L-lysine functionalised NaYF4:Yb,Er,Gd@NaYF4 core-shell upconverting 
nanoparticles were added and stirred for a further 2 h. The RB-lysine functionalised 
NaYF4:Yb,Er,Gd@NaYF4 core-shell nanoparticles were purified via centrifugation (21,000 xg, 30 min) 
three times until the supernatant was clear. The nanoparticles were dispersed in 4 mL DMSO. 
Estimation of the concentration of photosensitiser Rose Bengal on the UCNPs 
The photosensitiser loading on the RB-lysine functionalised NaYF4:Yb,Er,Gd@NaYF4 core-shell 
upconverting nanoparticles was estimated using UV-Vis absorption spectroscopy (εRB = 
90,400 M- 1·cm- 1). The number of the Rose Bengal molecules was divided by the number of 
nanoparticles calculated by ICP-OES measurements and the density of NaYF4 (3.87 g·cm-3).36 
Monitoring of singlet oxygen production 
The generation of singlet oxygen was monitored with 9,10-anthracenediyl-bis(methylene)dimalonic 
acid (ABMA, 1 µM), a molecular probe for singlet oxygen. The mass concentration of the nanoparticles 
was 0.55 mg·mL-1 dispersed in either DMSO or in McCOY’s 5A phenol red free cell culture medium. 
The nanoparticles were mixed with ABMA and the solution was placed in a stoppered quartz cuvette. 
The sample was irradiated with a 980 nm NIR laser (200 mW, Picotronic) for 40 min. The fluorescence 
emission intensity of ABMA was monitored every 5 min between 390 – 550 nm (λexc = 380 nm). 
 
Biological experiments 
A detailed description of the imaging medium, phosphate buffer saline and propidium iodide solution 
used to perform the biological studies can be found in the supporting information. The protocols used 
to culture the SK-BR-3 cells and to prepare the coverslips to be used with the confocal laser scanning 
microscope and the multi-photon microscope are also reported in the supporting information. 
 
 
9 
 
Treatment of SK-BR-3 cells to study cellular internalisation of the RB-lysine functionalised 
NaYF4:Yb,Er,Gd@NaYF4 core-shell UCNPs 
The SK-BR-3 cells on the coverslip were washed once with PBS (1 mL). For cells treated with the RB-
lysine functionalised NaYF4:Yb,Er,Gd@NaYF4 core-shell UCNPs, a solution of the functionalised UCNPs 
(1 mL, 25 µg·mL-1) in McCOY’s 5A phenol red free medium containing 0.25% DMSO was added to the 
coverslip. For control cells, 1 mL of McCOY’s 5A phenol red free medium was added to the coverslip. 
The cells were incubated for 3 h at 37 °C in a 5% CO2 atmosphere. Following incubation, the cells were 
washed three times with PBS (1 mL) and kept in McCOY’s 5A phenol red free medium supplemented 
with 10% foetal bovine serum (2 mL). Subsequently, the cells were imaged using multi-photon and 
laser scanning confocal microscopes. 
Treatment of SK-BR-3 cells to evaluate the PDT effect 
The SK-BR-3 cells on the coverslip were washed once with PBS (1 mL). For cells treated with the RB-
lysine functionalised NaYF4:Yb,Er,Gd@NaYF4 core-shell UCNPs, a solution of the functionalised UCNPs 
(1 mL, 15 µg·mL-1) in McCOY’s 5A phenol red free medium containing 0.25% DMSO was added to the 
coverslip. For control cells, 1 mL of the McCOY’s 5A phenol red free medium containing 0.25% DMSO 
was added to the coverslip. The cells were incubated for 3 h at 37 °C in a 5% CO2 atmosphere. Following 
incubation, the cells were washed three times with PBS (1 mL) and kept in McCOY’s 5A phenol red 
free medium supplemented with 10% foetal bovine serum (2 mL). The ‘irradiated cells’ were irradiated 
for 6 min per coverslip using a 980 nm near infrared (NIR) laser (200 mW, Picotronic) placed 50 mm 
above the lid of the 6-well Nunc multidish. A NIR detector card was placed under the well containing 
the coverslip during the irradiation of the sample to ensure that the laser light was at the centre of 
the treated coverslip. Both the irradiated and the non-irradiated SK-BR-3 cells were further incubated 
at 37 °C in a 5% CO2 atmosphere for ca. 24 h until the sample was imaged using a laser scanning 
confocal microscope. 
Imaging of treated SK-BR-3 cells using a multi-photon microscope 
For imaging, 18 mm coverslips containing the SK-BR-3 cells of interest were placed in a Ludin chamber, 
which was securely tightened. Each coverslip was washed three times with HBSS-based imaging 
medium and the Ludin chamber was mounted on a heated stage at 37 °C in a TriM Scope II multi-
photon microscope. The samples were excited with an 880 nm laser using a Vision II Ti: Sapphire laser 
(Coherent Ltd., Ely, UK) to collect the emission of the RB (green channel, 550 ± 42.5 nm) and the 
differential interference contrast (DIC). To collect the luminescence of the UCNPs, the sample was 
excited at 980 nm using the Vision II Ti:Sapphire laser with the emission collected with two non-
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descanned GaAsP detectors. The luminescence was measured in the green (550 ± 42.5 nm) and red 
(655 ± 20 nm) channels. 
Incubation of SK-BR-3 cells with propidium iodide 
Propidium iodide (5 µL, 1 mg·mL-1 in PBS) was mixed with HBSS-based imaging medium (1 mL). The 
solution was directly added to the coverslip that had been previously placed in a Ludin chamber for 
imaging (Life Imaging Service, Olten, Switzerland) and incubated at 37 °C in the dark on a heated stage 
of a Carl Zeiss LSM 510 META microscope for ca. 5 min. 
Imaging of treated SK-BR-3 cells using a laser scanning confocal microscope 
For imaging, 18 mm coverslips containing the SK-BR-3 cells were placed in a Ludin chamber, which 
was securely tightened. Each coverslip was washed three times with HBSS-based imaging medium and 
the Ludin chamber was mounted on a heated stage at 37 °C in a Carl Zeiss LSM 510 META microscope. 
A 543 nm HeNe laser was used to excite either the RB on the surface of the UCNPs or the propidium 
iodide with the emission collected between 560 – 615 nm in the red channel. DIC images were 
collected together with fluorescence images. DIC images were recorded with transmitted light at 488 
nm using an argon-ion laser. 
CellTiter-Blue® cell viability assay 
For the viability assays, SK-BR-3 cells were seeded on two 96-well white-bottom microplates ca. 48 h 
prior to treating the cells. The cells were cultured at 37 °C in a 5% CO2 atmosphere in a 75 cm2 tissue 
culture flask until they reached near confluence. At this point, the cells were washed with PBS and 
harvested from the flask using trypsin 0.25% (1x) EDTA as described previously. The cells were counted 
with a Neubauer haemocytometer and seeded at a density of 20x104 cells/mL (100 μL/well). The cells 
were incubated at 37 °C in a 5% CO2 atmosphere for ca. 48 h. Following incubation, the cells were 
washed once with PBS (100 μL). The RB-lysine functionalised NaYF4:Yb,Er,Gd@NaYF4 core-shell UCNPs 
(50 μL), at concentrations ranging between 10 – 20 μg·mL-1, in McCOY’s 5A phenol red free medium 
containing 0.25% DMSO were added to the wells. Cells without nanoparticles loaded were used as a 
control. A positive control for cytotoxicity, consisting of a solution of staurosporine (1 mM in DMSO) 
dispersed in McCOY’s 5A phenol red free medium (50 μL; 20 μM), was also used. A control for the 
effect of DMSO was also performed by treating the cells on the well with McCOY’s 5A phenol red free 
medium containing 0.25% DMSO. The cells were incubated with the UCNPs or the corresponding 
controls for 3 h at 37 °C in a 5% CO2 atmosphere. Following incubation, the cells were washed three 
times with PBS (100 μL) and kept in McCOY’s 5A phenol red free medium supplemented with 10% 
foetal bovine serum (100 μL). One of the 96-well microplates was irradiated using the 980 nm NIR 
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laser (200 mW, Picotronic) for 6 min per well. The laser was located 50 mm above the 96-well 
microplate. The other 96 well microplate, which was not irradiated, was covered in aluminium foil in 
the dark. Following irradiation (and non-irradiation), the cells were further incubated for ca. 48 h at 
37 °C in a 5% CO2 atmosphere. CellTiter-Blue® reagent (20 μL) was added to each well and incubated 
with the cells for 4 h at 37 °C in a 5% CO2 atmosphere. The fluorescence emission of the CellTiter-Blue® 
reagent was then measured at 594 nm following excitation at 561 nm using a CLARIOstar® (BMG 
Labtech) microplate reader. Background fluorescence was corrected by subtracting fluorescence 
emission from McCOY’s 5A phenol red free medium. Cell viability was calculated as a percentage of 
non-treated, non-irradiated cells. All of the samples were analysed in triplicate. 
 
Results and discussion 
Synthesis and characterisation of oleate-capped NaYF4:Yb,Er,Gd@NaYF4 core-shell upconverting 
nanoparticles 
The aim of the research here presented was to synthesise small, highly luminescent nanoparticles that 
could be readily uptaken by cells for PDT of cancer. Monodisperse β-NaYF4 nanoparticles doped with 
Yb3+, Gd3+ and Er3+ (β-NaYF4:Yb,Er,Gd core upconverting nanoparticles) were synthesised as the core 
material in high temperature boiling solvents following an Ostwald ripening strategy.6 The size of the 
core-nanoparticles was determined by TEM. Analysis of the TEM images indicated that the synthesised 
core UCNPs had a uniform shape and an average diameter of 16.2 ± 0.6 nm (Fig. S1). To achieve 
upconverting nanoparticles with an enhanced luminescence intensity, an inert shell was grown around 
the core nanoparticles. Cubic α-NaYF4 upconverting nanoparticles with a size of 2 – 3 nm (Fig. S2) were 
synthesised and used as shell precursors. The α-NaYF4 upconverting nanoparticles were injected 
stepwise to a solution of β-NaYF4:Yb,Er,Gd core UCNPs that was kept at 325 °C. After injection to the 
core particles, the cubic α-NaYF4 UCNPs dissolved and deposited in a hexagonal crystal lattice on the 
core UCNPs resulting in the oleate-capped NaYF4:Yb,Er,Gd@NaYF4 core-shell UCNPs.37 As expected, 
following addition of the shell material to the core nanoparticles, the size of the nanoparticles 
increased, as shown by the TEM images, from 16.2 ± 0.6 nm (Fig. S1, β-NaYF4:Yb,Er,Gd core UCNPs) to 
17.2 ± 1.0 nm (Fig. 2, NaYF4:Yb,Er,Gd@NaYF4 core-shell UCNPs). DLS measurements of both core and 
core-shell UCNPs also indicated an increase in the solvodynamic diameter, from 17.8 ± 2.6 nm to 
21.1 ± 3.1 nm, following formation of the shell (Fig. S3). The analysis of the composition of the core 
and core-shell nanoparticles by ICP-OES showed an increase in the Y3+ content concomitant with a 
decrease of the other Ln3+ ions from core to core-shell nanoparticles (Table S1). 
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Fig. 2. a) Transmission electron micrograph of a sample of oleate-capped NaYF4:Yb,Er,Gd@NaYF4 core-shell 
nanoparticles where the scale bar represents 60 nm. b) Histogram of the particle size distribution of oleate-
capped NaYF4:Yb,Er,Gd@NaYF4 core-shell nanoparticles with an average size of 17.2 ± 1.0 nm (n = 991). 
 
The luminescence spectrum of the β-NaYF4:Yb,Er,Gd core UCNPs recorded following NIR excitation at 
980 nm exhibited two main anti-Stokes emission bands subsequently referred to as the green emission 
(4S3/2  4I15/2) at 541 nm and the red emission (4F9/2  4I15/2) at 652 nm (Fig. 3a – i). The luminescence 
spectrum of the oleate-capped NaYF4:Yb,Er,Gd@NaYF4 core-shell UCNPs following excitation at 980 
nm exhibited also the green and red emission bands at 541 nm and 652 nm, respectively (Fig. 3a – ii). 
A comparison of the luminescence intensities of the core and core-shell nanoparticles following NIR 
irradiation at 980 nm shows an increase by a factor of 10 when the shell was present. The inactive 
inert shell minimises surface defects and solvent quenching effects.34, 38 To achieve high-energy 
transfer efficiency, a short distance should separate the emitting ions in the UCNPs from the 
photosensitiser. The short separation distance was achieved by depositing a lysine shell of small ca. 1 
nm thickness. 
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Fig. 3. Luminescence spectra of the a) (i) oleate capped β-NaYF4:Yb,Er,Gd core nanoparticles and (ii) 
NaYF4:Yb,Er,Gd@NaYF4 core-shell nanoparticles and b) (i) RB-lysine functionalised NaYF4:Yb,Er,Gd@NaYF4 core-
shell nanoparticles and (ii) NaYF4:Yb,Er,Gd@NaYF4 core-shell nanoparticles. The spectra were recorded in 
cyclohexane (a (i and ii) and b (ii)) and DMSO (b (i)) following excitation at 980 nm (cw 200 mW). In a) the spectra 
were normalised by the Yb3+ concentration determined by ICP-OES, to equal numbers of particles per sample.  
 
Synthesis and characterisation of the RB–lysine functionalised NaYF4:Yb,Er,Gd@NaYF4 core-shell 
upconverting nanoparticles 
Once the highly luminescent oleate-capped NaYF4:Yb,Er,Gd@NaYF4 core-shell UCNPs had been 
synthesised, the next step was their functionalisation with a photosensitiser to yield a platform that 
could be used for PDT of breast cancer cells. Rose Bengal (RB) was the chosen photosensitiser since 
its absorption spectrum overlaps the green luminescence emission band of the UCNPs at 541 nm. 
Thus, it was expected that, following excitation at 980 nm, the Rose Bengal would be activated via a 
FRET process to produce singlet oxygen. 
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Before incorporation of the RB, the surface of the oleate-capped NaYF4:Yb,Er,Gd@NaYF4 core-shell 
UCNPs was modified via a two-step ligand exchange method as indicated in Fig. S4. In the first step, 
NOBF4 was inserted in a two-phase system to remove oleate from the surface of the nanoparticles 
and to stabilise the uncoated particles. This first step resulted in BF4--capped NaYF4:Yb,Er,Gd@NaYF4 
core-shell UCNPs. In a second step, the ligand L-lysine was bound to the surface of the nanoparticles 
yielding lysine-capped NaYF4:Yb,Er,Gd@NaYF4 core-shell UCNPs. Water dispersibility of the 
nanoparticles was achieved following the incorporation of the lysine ligand. 
The photosensitiser RB was bound to the free amine groups of the lysine-capped 
NaYF4:Yb,Er,Gd@NaYF4 core-shell UCNPs via classical EDC/NHS chemistry yielding RB-lysine 
functionalised NaYF4:Yb,Er,Gd@NaYF4 core-shell UCNPs. During the surface modification, the 
nanoparticles show no tendency of agglomeration, as confirmed by the DLS measurements (Fig. S5). 
A decrease in the solvodynamic diameter of the nanoparticles was observed when the oleate ligand 
was replaced by BF4- (from ca. 21 to ca. 14 nm). As expected, the solvodynamic diameter increased to 
23.7 ± 8.4 nm following incorporation of the Rose Bengal to the lysine-capped NaYF4:Yb,Er,Gd@NaYF4 
nanoparticles. The Rose Bengal loading was estimated to be 160 RB molecules per nanoparticle, which 
is quite similar to the numbers of emitters in the nanoparticle. The RB-lysine functionalised 
NaYF4:Yb,Er,Gd@NaYF4 core-shell UCNPs exhibited colloidal stability in DMSO and water, and were 
stable in phosphate buffer and cell medium which enabled assessment of the nanoparticle 
performance for intracellular experiments. 
The surface architecture of the different types of functionalised nanoparticles was validated by FTIR 
measurements (Fig. S6). The FTIR spectrum of the oleate-capped NaYF4:Yb,Er,Gd@NaYF4 core-shell 
UCNPs exhibited strong C-H stretching at 2,926 and 2,851 cm-1 that disappeared, as expected, 
following ligand exchange with L-lysine. In addition to the C=O stretching (at 1,558 and 1,457 cm-1), a 
strong absorption band at 1,655 cm-1 attributed to the C-N bending was observed in the FTIR spectrum 
of the lysine-capped UCNPs. Following incorporation of the Rose Bengal, the band due to the amine 
bending was reduced and new absorption bands occurred at 1,543, 1,457 and 1,342 cm-1 that were 
attributed to the amide stretching and the C=C stretching of the aromatic rings of the photosensitiser. 
The C-H bending of the aromatic ring and the C-I bending were visible at 954 cm-1 and 700 cm-1, 
respectively. 
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Optical properties of the RB–lysine functionalised NaYF4:Yb,Er,Gd@NaYF4 core-shell upconverting 
nanoparticles 
Surface modification affects the luminescence characteristics of the UCNPs upon NIR excitation. The 
spectrum of the RB-lysine functionalised UCNPs shows the emission of the RB overlapping the typical 
upconversion luminescence (Fig. 3b), accompanied by the change of the predominately visible colour 
of the excited particles from green to red. The green (541 nm) to red (652 nm) ratio of the 
luminescence emission intensities of the oleate-capped core- shell UCNPs was 7.7:1 (Fig. 3b – ii) 
following 980 nm irradiation. The green to red ratio, under the same irradiation conditions, decreased 
to 0.6:1 for the RB-lysine functionalised core-shell UCNPs in DMSO (Fig. 3b – i) due to the presence of 
the photosensitiser Rose Bengal, which absorbs light in the region of ca. 550 nm. The luminescence 
spectra of lysine and RB-lysine functionalised core-shell UCNPs in water are reported in Fig. S7 
exhibiting green to red ratios of 5:1 and 0.5:1, respectively. The appearance of the emission of RB 
observed in Fig. 3b - i can be assigned to two effects: a) the so-called inner filter effect and b) Förster 
resonance energy transfer (FRET). Time-resolved spectroscopy revealed the FRET mechanism by 
comparing the lifetime of the two main emission peaks of the UCNPs before and after the attachment 
of the photosensitiser (Fig. S8 and Table S2). The lifetime of the green donor emission decreased from 
216 to 161 μs, yielding a FRET efficiency of 25%. The lifetime of the red emission measured at 
656 ± 50 nm, containing the long luminescence lifetime of the UCNPs and the short lifetime of RB, 
decreased from 342 to 266 μs. The acceptor luminescent lifetime of the RB is in the same range 
compared to the donor lifetime of the green emission. This demonstrates, by introducing L-lysine as 
short linker molecule, that the weak binding affinity of RB to the surface of the UCNPs was overcome 
and the distance of the acceptor and donor system was kept as short as possible to enable efficient 
FRET. 
 
Singlet oxygen production by the RB-lysine functionalised NaYF4:Yb,Er,Gd@NaYF4 core-shell UCNPs 
The ability of the RB-lysine functionalised UCNPs to produce singlet oxygen (1O2) following NIR 
excitation at 980 nm was investigated using the singlet oxygen probe 9,10-anthracenediyl-
bis(methylene) dimalonic acid (ABMA). ABMA is photobleached in the presence of 1O2 and thus the 
fluorescence emission of the probe is quenched upon reaction with 1O2. The production of 1O2 by the 
RB-lysine functionalised UCNPs was investigated in two different media: DMSO and McCOY’s 5A cell 
culture medium (Fig. 4). 
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In DMSO, the fluorescence emission intensity of ABMA was readily quenched over time (Fig. 4a and b 
– black) confirming the production of singlet oxygen by the RB photosensitiser on the surface of the 
UCNPs following NIR excitation at 980 nm. These results confirm the energy transfer between the 
UCNPs and the photosensitiser and the subsequent production of singlet oxygen. In cell culture 
medium, the production of singlet oxygen following irradiation of the RB-lysine UCNPs at 980 nm was 
significantly reduced (Fig. 4b – red) due to the quenching of the 1O2 and the absorption of the 980 nm 
light in the aqueous based medium. Further experiments demonstrate the importance of the short 
distance between the UCNPs and the photosensitiser for the production of singlet oxygen (Fig. S9). 
The singlet oxygen production of RB-lysine functionalised UCNPs in water was compared to that of 
lysine functionalised UCNPs in a solution containing dissolved RB. The comparison was performed in 
two solvents, DMSO and water. When the UCNPs were dispersed in an organic solvent like DMSO, 
both types of solutions produced more singlet oxygen than the reference system, RB-lysine 
functionalised UCNPs in water. These results suggest that the distance between the photosensitiser 
and the UCNPs is not relevant for the production of singlet oxygen in DMSO. The inner filter effect is 
sufficient to generate singlet oxygen. However, when the experiments were performed in water, 
production of singlet oxygen was only observed for RB-lysine functionalised UCNPs and not when the 
RB was in solution and non-covalently attached to the UCNPs. The results obtained in the aqueous 
media confirm that efficient energy transfer (FRET) is responsible for the production of singlet oxygen 
by the RB-lysine functionalised UCNPs. 
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Fig. 4. a) Time-dependent decay of the fluorescence emission spectrum of the singlet oxygen probe 9,10-
anthracenediyl-bis(methylene)dimalonic acid (ABMA, λexc = 380 nm) upon irradiation of the RB-lysine 
functionalised UCNPs with the NIR-laser (980 nm, cw, 200 mW, DMSO). b) Normalised decay of the fluorescence 
emission intensity of ABMA at 410 nm following irradiation of RB-lysine functionalised UCNPs in DMSO (black) 
and in McCOY’s 5A phenol red free cell culture medium (red). 
 
Cellular uptake of the RB-lysine functionalised NaYF4:Yb,Er,Gd@NaYF4 core-shell UCNPs 
The suitability of the RB-lysine functionalised UCNPs to act as PDT agents was studied intracellularly. 
The first step was to confirm the cellular uptake of the functionalised nanoparticles by SK-BR-3 human 
breast adenocarcinoma cells. SK-BR-3 cells were incubated with the RB-lysine modified UCNPs for 3 h 
and the internalisation of the nanoparticles by the cells was investigated using two imaging 
techniques, viz, multi-photon and laser scanning confocal microscopy. To confirm the internalisation 
of the RB-lysine functionalised UCNPs within the breast cancer SK-BR-3 cells using a multi-photon 
microscope, the samples were excited using two-photon excitation at two wavelengths: 1) 880 nm to 
excite the RB on the functionalised UCNPs and to collect the differential interference contrast (DIC) 
images (Fig. 5a – c and g – i); and 2) 980 nm to excite the UCNPs directly (Fig. 5d – f and j – l). Following 
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two-photon excitation at 880 nm, the fluorescence emission due to the RB on the UCNPs was observed 
in the green channel (550 ± 42.5 nm; Fig. 5b). This emission was not observed in control cells without 
the RB-lysine functionalised UCNPs loaded (Fig. 5h), confirming the presence of the photosensitiser 
within the SK-BR-3 cells treated with the RB-lysine functionalised UCNPs. No fluorescence emission 
was observed in the red channel (655 ± 20 nm) following 880 nm irradiation for the cells treated with 
the functionalised UCNPs (Fig. 5c) or for the control cells without UCNPs (Fig. 5i). This indicates that 
the fluorescence observed in the green channel for cells treated with the RB-lysine functionalised 
UCNPs was due to the RB on the particles. Following 980 nm irradiation, the direct luminescence from 
the functionalised UCNPs was observed in both the green and in the red channels (Fig. 5e and f, 
respectively) as expected from the luminescence spectrum of the UCNPs. This result confirms the 
uptake of the RB functionalised UCNPs by the SK-BR-3 cells. The upconversion luminescence images 
of the RB-lysine functionalised UCNPs within the SK-BR-3 cells (Fig. 5e and f) appeared to be ‘blurred’ 
and of poor resolution. Low resolution images of UCNPs obtained using two-photon laser scanning 
microscopy have been previously reported and are associated with the presence of axial interferences 
from out-of-focus light together with lateral interferences from scattering within the focal plane. The 
quality of the upconversion luminescence images could be improved using a microscope equipped 
with a confocal pinhole, which would eliminate both the axial and lateral interferences.39 Despite the 
blurred images (Fig. 5e and f), it is clear that the RB-lysine functionalised UCNPs are successfully 
emitting upconversion luminescence from within the cancer cells. No upconversion luminescence was 
observed when control cells with no RB-lysine functionalised UCNPs were imaged following irradiation 
using the 980 nm NIR laser under the same conditions (Fig. 5k and l). 
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Fig. 5. Multi-photon microscopy images of SK-BR-3 cells: a – f) incubated with RB-lysine functionalised UCNPs 
(25 µg·mL-1) and g – l) control cells without functionalised UCNPs. DIC images were obtained using an 880 nm 
laser (a and g). The emission was collected in the green (550 ± 42.5 nm; b, e, h and k) and red (655 ± 20 nm; c, f, 
i and l) channels following excitation at either 880 or 980 nm. Scale bars: a – f) 20 µm and g – l) 30 µm. 
 
The experiments performed using the confocal microscope also confirmed the internalisation of the 
RB functionalised UCNPs within the SK-BR-3 cells. The cells were incubated with the RB-lysine 
functionalised UCNPs for 3 h and the emission due to the RB on the nanoparticles was collected in the 
red channel (560 – 615 nm) following excitation with a 543 nm HeNe laser (Fig. 6a - c). The morphology 
of the treated cells was observed in the DIC images obtained with transmitted light at 488 nm. Laser 
scanning confocal microscopy images of the treated cells (Fig. 6a – c) show an intense red emission 
due to the RB of the functionalised UCNPs within the cells that was not observed in control cells (Fig. 
6d – f). Morphological changes were not observed for either of the cell samples suggesting that the 
RB-lysine UCNPs were not toxic to the cells. 
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Fig. 6. Laser scanning confocal microscopy images of SK-BR-3 cells: a – c) incubated with RB-lysine functionalised 
UCNPs (25 µg·mL-1) and d – f) control cells without functionalised UCNPs. DIC images were obtained using a 488 
nm laser (a and d). The emission due to the RB on the UCNPs was collected in the red channel (560 – 615 nm; b 
and e) following excitation at 543 nm. Images c and f are composite images of the DIC and red channels. Scale 
bars are 5 µm. 
 
Suitability of the RB-lysine functionalised NaYF4:Yb,Er,Gd@NaYF4 UCNPs for photodynamic therapy 
of breast cancer cells 
To establish the efficacy of the functionalised UCNPs as PDT agents, a CellTiter-Blue® cell viability 
assay40 was performed in vitro. This assay provides information regarding the number of viable cells 
present in the wells of a 96-well plate by measuring the metabolic capacity of the studied cells. Viable 
cells are able to reduce the indicator dye resazurin into a fluorescent product, resorufin, the 
fluorescence emission intensity of which can be measured at 594 nm using a microplate reader upon 
excitation at 561 nm. Conversely, non-viable cells lose their metabolic capacity and are not able to 
reduce resazurin thus are unable to generate a measurable fluorescent signal. SK-BR-3 cells were 
seeded on 96-well microplates and incubated with varying concentrations of RB-lysine functionalised 
UCNPs for 3 h. A positive control for cytotoxicity, consisting of cells treated with staurosporine, was 
also included in the assay. Following incubation with the RB-lysine functionalised UCNPs, the cells 
were thoroughly washed with PBS to remove the nanoparticles that had not been internalised by the 
SK-BR-3 cells. The cells were subjected to PDT by irradiation with a NIR 980 nm laser for 6 min per 
well. 
Control experiments where cells incubated with the varying concentrations of RB-lysine functionalised 
UCNPs and with staurosporine were kept in the dark and not irradiated were also performed. Cell 
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viability of the SK-BR-3 cells was assessed 48 h following PDT treatment (Fig. 7). A decrease in cell 
viability concomitant with an increase in the concentration of RB-lysine functionalised UCNPs (from 0 
to 20 µg·mL-1) can be observed following PDT treatment of the SK-BR-3 cells. However, at high 
concentrations (i.e. ≥ 20 µg·mL-1) the nanoparticles exhibited some dark toxicity as indicated by the 
decrease in viability of cells that had been incubated with the functionalised UCNPs but had not been 
irradiated. At a concentration of functionalised UCNPs of 15 µg·mL-1, 67% of the cells were killed 
following PDT while the dark toxicity of the nanoparticles was minimal (5%). The effect that the DMSO 
used to solubilise the functionalised UCNPs had on the viability of the cells was also investigated. No 
cell-death was observed when the SK-BR-3 cells were treated with McCOY’s 5A phenol red free 
medium containing 0.25% DMSO for 3 h confirming that, under the conditions used to perform the 
cell viability assay, DMSO was not toxic for the cells. The results from the CellTiter-Blue® cell viability 
assay suggested that a concentration of 15 µg·mL-1 of the RB-lysine functionalised UCNPs was ideal for 
PDT.  
 
Fig. 7. CellTiter-Blue® cell viability assay of SK-BR-3 cells that were incubated with varying concentrations (from 
0 to 20 µg·mL-1) of RB-lysine functionalised UCNPs for 3 h and irradiated (orange) or non-irradiated (green) with 
the 980 nm NIR laser for 6 min. +ve St indicates SK-BR-3 cells that had been treated with staurosporine – a 
positive control for cytotoxicity. DMSO indicates SK-BR-3 cells that had been treated with McCOY’s 5A phenol 
red free medium containing 0.25% DMSO for 3 h. Each experiment was repeated in triplicate and the relative 
standard error is indicated by the error bars. Statistically significant difference between non-irradiated and 
irradiated samples is indicated by * at P < 0.04; ** at P < 0.0006 and *** at P < 0.00007, obtained using a two-
tailed Student’s t-test, where P < 0.05 is considered statistically significant. 
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Laser scanning confocal fluorescence microscopy was used to further determine the suitability of the 
functionalised UCNPs for PDT. SK-BR-3 cells seeded on coverslips were treated with the RB-lysine 
functionalised UCNPs (15 µg·mL-1) for 3 h. Following removal of non-uptaken nanoparticles by 
washing, singlet oxygen was activated by irradiating the UCNPs within the cells with the 980 nm NIR 
laser for 6 min. The treated cells were imaged using confocal laser scanning microscopy ca. 24 h 
following PDT treatment (Fig. 8a – c). DIC images of the SK-BR-3 cells clearly show degradation of the 
cell membrane, which was indicative of cell death (Fig. 8a and d). The RB-lysine functionalised UCNPs 
accumulated in the nucleus of the SK-BR-3 cells that had been irradiated with the 980 nm NIR laser 
(Fig. 8b and c). The accumulation of the particles in the nucleus of the cells was not observed for non-
irradiated SK-BR-3 cells that had been incubated with the RB-lysine functionalised UCNPs (Fig. 8j – l 
and Fig. S10). This result suggests that the location of the UCNPs in the nucleus, seen in Fig. 8b and c, 
following NIR PDT could be indicative of cell death. Furthermore, the cells that had been treated with 
the RB-lysine functionalised UCNPs and irradiated with the 980 nm NIR laser subsequently stained 
positive when incubated with propidium iodide (Fig. 8d – f and Fig. S11) confirming the cell death 
following PDT treatment.41 
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Fig. 8. Laser scanning confocal microscopy images of SK-BR-3 cells: a – f) incubated with the RB-lysine 
functionalised UCNPs (15 µg·mL-1) and irradiated with the 980 nm laser before (a – c) and following (d – f) 
addition of propidium iodide; g – i) without RB-lysine functionalised UCNPs, irradiated with the 980 nm laser and 
treated with propidium iodide; and j – l) incubated with the RB-lysine functionalised UCNPs (15 µg·mL-1), non-
irradiated with the 980 nm laser and treated with propidium iodide. DIC images were obtained using a 488 nm 
laser (a, d, g and j). The fluorescence emission due to the RB on the UCNPs and the propidium iodide was 
collected in the red channel (560 – 615 nm; b, e, h and k) following excitation at 543 nm (laser power 4%). Images 
c, f, i and l are composite images of the red and DIC channels. Scale bars are 10 µm. 
 
The changes of cellular membrane integrity or the positive stain for propidium iodide were not 
observed for the control experiments. These included: the SK-BR-3 cells without functionalised UCNPs 
that had been irradiated with the 980 nm NIR laser for 6 min (Fig. 8g – i); the non-irradiated SK-BR-3 
cells incubated with the functionalised UCNPs (Fig. 8j – l); and the non-irradiated SK-BR-3 cells without 
functionalised UCNPs (Fig. S12). The laser power used to image the SK-BR-3 cells treated with 
propidium iodide was too low (4%) to be able to observe the fluorescence emission due to the 
internalised RB-lysine functionalised UCNPs in the non-irradiated SK-BR-3 cells shown in Fig. 8j – l. To 
confirm the presence of the RB-lysine functionalised UCNPs in the non-irradiated SK-BR-3 cells, images 
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using a higher laser power (100%) were obtained prior to the addition of the propidium iodide and 
compared with the control non-irradiated SK-BR-3 cells without RB-lysine functionalised UCNPs 
imaged under the same conditions (Fig. S10). The fluorescence emission due to the RB from the SK-
BR-3 cells that had been treated with the RB-lysine functionalised UCNPs was not observed for the 
control cells, thus confirming the internalisation of the RB-lysine functionalised UCNPs by the SK-BR-3 
cells and the importance of NIR 980 nm irradiation to induce cell death via PDT. The results shown in 
Fig. 8 and Fig. S10 – S12 highlight that the RB-lysine functionalised UCNPs are ideal photosensitiser 
vehicles for PDT of breast cancer cells. 
 
Conclusions 
Highly luminescent lanthanide doped core-shell upconverting nanoparticles have been synthesised 
and functionalised with the photosensitiser Rose Bengal via an amino acid (L-lysine) linker. The short 
distance between the photosensitiser and the light emitting core has proven efficient for a high energy 
transfer from the UCNPs core to the RB via a FRET process. The FRET process, confirmed from 
luminescence lifetime measurements, allowed for the excitation of the photosensitiser and thus the 
production of singlet oxygen using NIR light at 980 nm. The RB-lysine functionalised UCNPs were 
successfully used for PDT of SK-BR-3 breast cancer cells. The efficient internalisation of the RB-lysine 
functionalised UCNPs by the cells was confirmed using confocal laser scanning microscopy and multi-
photon microscopy, which clearly showed the emission from both the RB and the UCNPs only inside 
the treated cells. Following internalisation of the functionalised UCNPs, the SK-BR-3 cells were 
irradiated with a 980 nm laser to induce the production of singlet oxygen by RB. Cell viability assays 
showed high levels of cell death following irradiation, reaching ca. 67% of cell death at a RB-lysine 
functionalised UCNP concentration of only 15 µg·mL-1. Additionally, at this concentration, the RB-
lysine functionalised UCNPs were shown to induce negligible dark toxicity of the SK-BR-3 cells that had 
not been irradiated. The efficient cell death post-PDT was also confirmed using confocal microscopy 
and the dead cell marker propidium iodide. Only those cells that had been incubated with the RB-
lysine functionalised UCNPs and irradiated with NIR light at 980 nm stained positive with propidium 
iodide, thus confirming the cell death following PDT treatment. The confocal microscopy experiments 
also showed accumulation of the UCNPs in the nucleus of the SK-BR-3 cells, only in samples that had 
been irradiated with NIR light to induce production of singlet oxygen. Control cells, treated with the 
functionalised nanoparticles but not irradiated, did not show accumulation of the UCNPs within the 
nucleus. For future applications, targeting agents could be incorporated onto the surface of the 
nanoparticles yielding a vehicle for targeted photodynamic therapy to further improve the efficiency 
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of the treatment and reduce any possible damage of healthy cells. Furthermore, to complement the 
treatment potential of the nanoplatform, the nanocrystals doped with Gd3+ can also be used as a 
multimodal diagnostic tool for magnetic resonance imaging (MRI). 
The synthesised efficient RB-lysine functionalised UCNPs are shown to be successful candidates for 
PDT of breast cancer cells using NIR light. The NIR irradiation opens the possibility to use the reported 
nanoplatform to treat deep lying tumours. 
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